---
title: "URGN.US (URGN.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/URGN.US/news.md"
symbol: "URGN.US"
name: "URGN.US"
parent: "https://longbridge.com/en/quote/URGN.US.md"
datetime: "2026-03-13T21:45:34.632Z"
locales:
  - [en](https://longbridge.com/en/quote/URGN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/URGN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/URGN.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/URGN.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/URGN.US/news.md)


# URGN.US (URGN.US) — Related News

### [Building Momentum With Zusduri: Strong Early Commercial Traction, Expanding Physician Adoption, and Pipeline-Funded Upside Support a Buy Rating](https://longbridge.com/en/news/278440791.md)
*2026-03-09T18:55:25.000Z*
> Urogen Pharma received a Buy rating from analyst Tara Bancroft of TD Cowen, with a price target of $35.00. The rating is

### [UroGen Pharma Earnings Call: Launch Momentum Meets Rising Costs](https://longbridge.com/en/news/278300850.md)
*2026-03-09T00:28:43.000Z*
> UroGen Pharma's Q4 earnings call highlighted strong product momentum and clinical data, despite widening losses and risi

### [UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | URGN Stock News](https://longbridge.com/en/news/278166899.md)
*2026-03-06T13:10:00.000Z*
> UroGen Pharma Ltd. announced the grant of inducement restricted stock units (RSUs) to 11 new employees as part of their 

### [Top 10 US Stock Losers (3.2)](https://longbridge.com/en/news/277524813.md)
*2026-03-02T22:01:11.000Z*
> Uniqure(QURE) fell 32.82%, with a trading turnover 164.5 Million USD, and a year-to-date fell 56.1%. Turning Point Brand

### [UroGen Announces Refinanced Term Loan Agreement with Pharmakon Advisors | URGN Stock News](https://longbridge.com/en/news/277467774.md)
*2026-03-02T04:55:00.000Z*
> UroGen Pharma Ltd. has announced a refinancing agreement with Pharmakon Advisors, reducing its cost of capital to 8.25% 

### [UroGen Pharma Secures New $250 Million Term Loan](https://longbridge.com/en/news/277474760.md)
*2026-03-02T13:36:22.000Z*
> UroGen Pharma has secured a new $250 million term loan agreement with BioPharma Credit-affiliated lenders. The loan incl

### [Urogen Pharma (NASDAQ:URGN) Posts Quarterly Earnings Results, Beats Expectations By $0.11 EPS](https://longbridge.com/en/news/277473017.md)
*2026-03-02T13:29:21.000Z*
> Urogen Pharma (NASDAQ:URGN) reported quarterly earnings, posting an EPS of ($0.54), exceeding analysts' expectations of 

### [UroGen Pharma 2025 10-K: $109.8M Revenue, $(3.19) Net Loss per Share](https://longbridge.com/en/news/277471012.md)
*2026-03-02T13:15:01.000Z*
> UroGen Pharma reported $109.8 million in revenue for 2025, an increase of $19.4 million from 2024, driven by product lau